Becton Dickinson and Co at Morgan Stanley Global Healthcare Conference Transcript
Amazing. Thank you so much and welcome, everyone. Before we start, I get the fun disclosures, morganstanley.com/researchdisclosures. I'm just timing this right down, go there. I'm sure you all will, or you can reach out to your MS sales rep. Patrick Wood, U.S. med tech team. And welcome, everyone. Big thank you, of course, the entire BD team. Obviously, we've got Chris, we've got Mike, and we got Dave across the Head of Medical segment, across Life Sciences and of course, as CFO. Thank you so much for joining us and agreeing to do this.
Questions & Answers
Well, we'll we kick off with, how about 2024 margins? You guys are running a little bit ahead, I would say. See how the year closes, but maybe where you were hoping to be on the margin structure side of things. How are you thinking about the interplay between reinvestment and margins going forward?
Yes, yes. No, I appreciate the question. Thanks
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
